In case 2, assessing the gene expression levels for SF-1 and CYP19A1 in the tumor by RT-qPCR showed that they were consistent with the results of immunohistochemical studies; both SF-1 and CYP19A1 genes were expressed in the tumor. The gene discussed is CYP19A1; the disease is neoplasm.